MS170 is a highly effective and specific PROTAC AKT degrader compound that exhibits potent activity. It efficiently reduces the levels of total AKT (T-AKT) within cells, with a DC 50 value of 32 nM. Furthermore, MS170 demonstrates strong binding affinity towards AKT isoforms, specifically AKT1, AKT2, and AKT3, with respective dissociation constants (Kd) of 1.3 nM, 77 nM, and 6.5 nM.This compound is unstable in powder form and other related salt forms are recommended.

BBO-10203（又称 Compound 758）是一种可口服的小分子化合物，通过结合 PI3Kα 的 Ras 结合域，选择性地阻断 PI3Kα-Ras 相互作用。BBO-10203 有效阻止 Ras-PI3Kα 复合物形成，并抑制下游 Akt 激活，而不影响基础 PI3Kα 激酶活性，从而降低高血糖与高胰岛素血症风险；BBO-10203对 KRAS 突变肿瘤具有选择性抗肿瘤活性，是靶向癌症研究的重要候选分子。

Peptide substrate for Akt/PKB

Gamendazole is a novel drug candidate for male contraception. It has been shown to reduce fertility in male rats without affecting testosterone levels.

Cholesta-3,5-diene 是一种针对免疫细胞（如中性粒细胞）的炎症调节剂，通过促进中性粒细胞趋化和成纤维细胞迁移以加速伤口愈合。它通过激活趋化因子受体介导的信号通路（如PI3K/Akt），增强免疫细胞的召集和细胞外基质的沉积。Cholesta-3,5-diene 可用于局部伤口修复，特别是在慢性溃疡或皮肤损伤中展现出潜在的治疗功效。

Notoginsenoside R4 可从人参根部提取，并能与 STAT3、AKT1、HRAS、VEGFA 与 CASP3 等疾病核心靶点发生分子对接，显示良好的结合亲和力。相关对接与可视化分析表明，Notoginsenoside R4 是三七皂苷（PNS）中关键的功能成分之一，具有调控抗癌与促凋亡信号的潜在机制价值。